Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion type Assertion NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_head.
- NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion wasGeneratedBy ECO_0000203 NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_provenance.
- NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion wasDerivedFrom gad-20150221 NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_provenance.
- NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion SIO_000772 11927838 NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_provenance.
- NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion evidence source_evidence_literature NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_provenance.
- NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_assertion description "[Statistically significant increases in asthma risk were also observed among the whole study population for the concurrent presence of the GSTM1 null genotype and either NAT1 (odds ratio OR 4.53, 95% CI 1.76 to 11.6) or NAT2 (OR 3.12, 95% CI 1.11 to 8.78) slow acetylator genotypes, and of NAT1 and NAT2 slow acetylator genotypes (OR 4.20, 95% CI 1.51 to 11.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73685.RASPWAluwQ7HE9FD3gZ9MOUsgXbu2xa9E-67RqN6ONHJI130_provenance.